By ANDREW POLLACK
Moderna Therapeutics said the financing brought the funds it had raised from investors and corporate partners to more than $950 million, a remarkable figure for a company that does not have an experimental drug in clinical trials.
Published: January 5, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1BCbwTk
from WordPress http://ift.tt/1wewWm4
via Hadi Aboukhater
No comments:
Post a Comment